Omeros Corporation share price logo

Omeros Corporation

NASDAQ: OMER

Small Cap

$12.38

+0.41

(+3.43%)

as on

Omeros Corporation Stock Performance

as on May 21, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $12.00
    $12.55
    downward going graph

    3.07%

    Downside

    1.37%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.95
    $17.65
    downward going graph

    76.17%

    Downside

    42.57%

    Upside

    downward going graph

Omeros Corporation share price movements today

Previous Close
$11.97
Open
$12.23
Volume
1.1M
Day's Low - High
$12.00 - $12.55
52 Week Low - High
$2.95 - $17.65

Omeros Corporation Historical Returns

1 Month Return
-6.64 %
3 Month Return
+ 2.82 %
1 Year Return
+ 298.07 %
3 Year Return
+ 97.76 %
5 Year Return
-16.86 %

Omeros Corporation Stock Fundamentals & Key Indicators

Check Omeros Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$896.0M

EPS (TTM)

0.4233

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

10.86

Industry PE ratio

-4.066872146118722

PEG Ratio

0.8053

EBITDA

-104.3M

Revenue (TTM)

9.9M

Profit Margin

871.02%

Return On Equity TTM

-576.33%

Omeros Corporation Stock Valuation

Track how Omeros Corporation P/E has moved over time to understand its valuation trends.

Omeros Corporation in the last 5 years

  • Overview

  • Trends

Lowest (-34.73x)

March 31, 2026

Industry (-4.07x)

May 21, 2026

Today (10.86x)

May 21, 2026

Highest (12.53x)

September 30, 2023

LowHigh

Today’s Price to Earnings Ratio: 10.86x

Omeros Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Omeros Corporation with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$896.0M-16.86%10.86871.02%
BUY$39.3B113.11%74.1312.55%
BUY$110.2B101.68%25.7835.51%
BUY$66.1B28.23%15.3829.65%

Stock Returns calculator for Omeros Corporation Stock including INR - Dollar returns

The Omeros Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Omeros Corporation investment value today

Current value as on today

₹4,47,632

Returns

₹3,47,632

(+347.63%)

Returns from Omeros Corporation Stock

₹2,98,071 (+298.07%)

Dollar Impact

₹49,561 (+49.56%)

Analyst Recommendation on Omeros Corporation Stock

Based on 9 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 9 analysts, 66.67% of analysts recommend a 'BUY' rating for Omeros Corporation. Average target price of $33.5

Omeros Corporation Share Price Target

Get share price movements and forecasts by analysts on Omeros Corporation.

What analysts predicted

63.04%UPSIDE

Target Price

$33.5

Current Price

$12.38

Analyzed by

9 Analysts

Target

$33.50

Omeros Corporation target price $33.5, a slight upside of 63.04% compared to current price of $12.38. According to 9 analysts rating.

Indian Investors' Interest in Omeros Corporation Stock

Search interest for Omeros Corporation Stock has increased by 58% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:58% versus previous 30 day period

Omeros Corporation Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
1
-
-
-
0
-
-
-
9
Gross Profit
0
0
0
0
-
0
-10
-
-
9
Operating Income
-48
-39
-59
-35
-35
-34
-32
-26
-29
-17
EBITDA
-43
-35
-55
-32
-33
-33
-32
-26
-28
-17
Interest Expense
7
8
9
4
3
3
0
13
16
5
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-51
-43
-65
-37
-36
-37
-25
-21
81
51
Income Tax Expense
0
-6
-9
4
-
-
-
-
2
0
Net Income
-37
-37
-56
-32
-31
-33
-25
-30
86
56
Net Profit Margin
0.00%
-2722.11%
0.00%
0.00%
0.00%
-8121.36%
0.00%
0.00%
0.00%
566.66%

Omeros Corporation Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
41
64
29
111
73
90
-
-
-
-
Gross Profit
40
63
29
109
-1
-1
0
-69
0
-
Operating Income
-54
-43
-112
-63
-156
-173
-163
-164
-169
-122
EBITDA
-58
-41
-122
-60
-168
-170
-158
-143
-157
-121
Interest Expense
7
11
16
22
26
19
22
14
24
0
Depreciation
-
0
0
1
1
1
0
0
0
0
Income Before Tax
-66
-53
-139
-84
-196
-191
-182
-174
-182
-2
Income Tax Expense
8
11
-12
22
-23
-365
-210
-57
25
2
Net Income
-66
-53
-126
-84
-138
-111
47
-117
-156
-3
Net Profit Margin
-160.38%
-82.50%
-424.39%
-75.57%
-187.04%
-123.08%
0.00%
0.00%
0.00%
0.00%

Omeros Corporation Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-37
-65
-32
-31
-37
-25
-30
86
51
Operating Cash Flow
-41
-45
-32
-28
-35
-21
-18
-39
-14
Investing Cash Flow
-61
73
36
-
38
21
-6
111
28
Financing Cash Flow
98
-26
-4
-4
-1
-1
25
-64
-21
Change in Cash
-5
0
0
1
0
-2
0
7
-7

Omeros Corporation Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-53
-126
-84
-138
-191
-182
-117
-156
-3
Operating Cash Flow
-36
-103
-60
-100
-109
-86
74
-148
-116
Investing Cash Flow
-37
25
-3
-67
193
-127
27
82
164
Financing Cash Flow
74
81
60
174
6
124
-106
62
-42
Change in Cash
1
2
-2
7
90
-89
-3
-3
6

Global Institutional Holdings in Omeros Corporation

Funds
Holdings
Nomura Holdings Inc
0.91%
Millennium Management LLC
0.61%
Northern Trust Corp
0.73%
Ingalls & Snyder LLC
4.79%
UBS Group AG
0.98%

Omeros Corporation News & Key Events

  • img

    Today's Timeline - 15 October

    Wed, 09:07 PM

    -

    Omeros eligible for $340 million upfront and up to $2.1 billion in milestone payments from Novo Nordisk deal.

    Wed, 11:05 PM

    -

    Omeros announces asset purchase agreement for zaltenibart, a drug for rare blood and kidney disorders.

    Thu, 07:06 AM

    -

    Omeros stock surged 154.15% to $10.42 after $2.1 billion deal with Novo Nordisk.

Insights on Omeros Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, OMER stock has moved up by 284.9%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, OMER has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, OMER has outperformed top 5 stocks with highest market-cap in its industry

About Omeros Corporation

Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. The company's lead products candidate is the Narsoplimab (OMS721/MASP-2) for the treatment of hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); and in Phase II clinical trial to treat COVID-19 and acute respiratory distress syndrome. It also develops OMS1029 that has completed phase I clinical trials for mannan-binding lectin-associated serine protease 2 (MASP-2) and lectin pathway disorders; and OMS527 that is in phase I clinical trials for addictions and compulsive disorders, and movement disorders, as well as cocaine use disorder. In addition, the company's products under preclinical development comprise MASP-2, a pro-inflammatory protein target for the treatment of lectin pathway disorders; MASP-3 small-molecule inhibitors for alternative pathway disorders; OncotoX-AML, to treat acute myeloid leukemia; and Targeted Complement Activating Therapy, for Multidrug-resistant organisms. Omeros Corporation was incorporated in 1994 and is headquartered in Seattle, Washington.
OrganisationOmeros Corporation
HeadquartersThe Omeros Building, Seattle, WA, United States, 98119
IndustryBiotechnology
CEODr. Gregory A. Demopulos M.D.
E-voting on sharesClick here to vote

Key Management of Omeros Corporation

Name

Title

Mr. David W. Ghesquiere

VP & Chief Business Development Officer

Dr. Gregory A. Demopulos M.D.

Co-Founder, Chairman, CEO & President

Mr. David J. Borges

VP of Finance, Chief Accounting Officer & Treasurer

Mr. Peter B. Cancelmo J.D.

VP, General Counsel & Corporate Secretary

Dr. Pamela Pierce Palmer M.D., Ph.D.

Co-Founder

Dr. George A. Gaitanaris M.D., Ph.D.

Chief Scientific Officer & VP of Science

Mr. Peter W. Williams

Vice President of Human Resources

Dr. Catherine A. Melfi Ph.D.

Chief Regulatory Officer & VP of Regulatory Affairs and Quality Systems

FAQs

What is Omeros Corporation share price today?

Omeros Corporation share price today is $12.38 as on at the close of the market. Omeros Corporation share today touched a day high of $12.55 and a low of $12.

What is the 52 week high and 52 week low for Omeros Corporation share?

Omeros Corporation share touched a 52 week high of $17.65 on and a 52 week low of $2.95 on . Omeros Corporation stock price today i.e. is closed at $12.38,which is 29.86% down from its 52 week high and 319.66% up from its 52 week low.

What is Omeros Corporation's market capitalisation today?

Omeros Corporation market capitalisation is $0.00T as on .

How to invest in Omeros Corporation Stock (OMER) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Omeros Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Omeros Corporation Shares that will get you 0.1212 shares as per Omeros Corporation share price of $12.38 per share as on May 21, 2026 at 8:46 am IST.

What is the minimum amount required to buy Omeros Corporation Stock (OMER) from India?

Indian investors can start investing in Omeros Corporation (OMER) shares with as little as ₹96.19 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹961.90 in Omeros Corporation stock (as per the Rupee-Dollar exchange rate as on ). Based on Omeros Corporation share’s latest price of $12.38 as on May 21, 2026 at 8:46 am IST, you will get 0.8078 shares of Omeros Corporation. Learn more about fractional shares .

What are the returns that Omeros Corporation has given to Indian investors in the last 5 years?

Omeros Corporation stock has given -16.86% share price returns and 31.96% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?